Galectin-3 and HBME-1 improve the accuracy of core biopsy in indeterminate thyroid nodules

Endocrine

Volumn 52, Issue 1, 2016, Pages 39-45

  Trimboli, Pierpaolo ^a   Guidobaldi, Leo ^a   Amendola, Stefano ^a   Nasrollah, Naim ^a   Romanelli, Francesco ^b   Attanasio, Daniela ^c   Ramacciato, Giovanni ^d   Saggiorato, Enrico ^e   Valabrega, Stefano ^d   Crescenzi, Anna ^f  

^a Piazza San Bartolomeo All'Isola 21   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Azienda Sanitaria Locale   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Centre Hospitalier des Escartons   (France)

^f Unit of Hematology Stem Cell Transplantation   (Italy)

Author keywords

Core needle biopsy (CNB); Galectin 3; Nodule; Thyroid

Indexed keywords

CYTOKERATIN 19; GALECTIN 3; HBME 1 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; HBME-1 ANTIGEN; KERATIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CONTROLLED STUDY; CORE BIOPSY NEEDLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; ONCOCYTOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID SURGERY; THYROIDITIS; LARGE CORE NEEDLE BIOPSY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; REPRODUCIBILITY; THYROID TUMOR;

ADULT; AGED; BIOMARKERS; BIOMARKERS, TUMOR; BIOPSY, LARGE-CORE NEEDLE; FEMALE; GALECTIN 3; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; THYROID NODULE;

EID: 84961583756     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-015-0678-7     Document Type: Article

References (32)

1. H. Gharib, E. Papini, R. Paschke, D.S. Duick, R. Valcavi, L. Hegedüs, P. Vitti, AACE/AME/ETA Task Force on Thyroid Nodules, American association of clinical endocrinologists, associazione medici endocrinologi, and europeanthyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr. Pract. 1, 1–43 (2010)
2. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, D.S. Cooper, G.M. Doherty, B.R. Haugen, R.T. Kloos, S.L. Lee, S.J. Mandel, E.L. Mazzaferri, B. McIver, F. Pacini, M. Schlumberger, S.I. Sherman, D.L. Steward, R.M. Tuttle, Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009)
3. P. Trimboli, G. Treglia, L. Guidobaldi, E. Saggiorato, G. Nigri, A. Crescenzi, F. Romanelli, F. Orlandi, S. Valabrega, R. Sadeghi, L. Giovanella, Clinical characteristics as predictors of malignancy in patients with indeterminate thyroid cytology: a meta-analysis. Endocrine 46, 52–59 (2014)
4. P. Trimboli, E. Condorelli, A. Catania, S. Sorrenti, Clinical and ultrasound parameters in the approach to thyroid nodules cytologically classified as indeterminate neoplasm. Diagn. Cytopathol. 37, 783–785 (2009)
5. E.K. Alexander, G.C. Kennedy, Z.W. Baloch, E.S. Cibas, D. Chudova, J. Diggans, L. Friedman, R.T. Kloos, V.A. LiVolsi, S.J. Mandel, S.S. Raab, J. Rosai, D.L. Steward, P.S. Walsh, J.I. Wilde, M.A. Zeiger, R.B. Lanman, B.R. Haugen, Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N. Engl. J. Med. 367, 705–715 (2012)
6. E. Saggiorato, Pompa R. De, M. Volante, S. Cappia, F. Arecco, A.P. Dei Tos, F. Orlandi, M. Papotti, Characterization of thyroid ‘follicular neoplasms’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr. Relat. Cancer 12, 305–317 (2005)
7. A. Bartolazzi, F. Orlandi, E. Saggiorato, M. Volante, F. Arecco, R. Rossetto, N. Palestini, E. Ghigo, M. Papotti, G. Bussolati, M.P. Martegani, F. Pantellini, A. Carpi, M.R. Giovagnoli, S. Monti, V. Toscano, S. Sciacchitano, G.M. Pennelli, C. Mian, M.R. Pelizzo, M. Rugge, G. Troncone, L. Palombini, G. Chiappetta, G. Botti, A. Vecchione, R. Bellocco, Italian Thyroid Cancer Study Group (ITCSG), Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet. Oncol. 9, 543–549 (2008)
8. G. Fadda, E.D. Rossi, M. Raffaelli, A. Pontecorvi, S. Sioletic, F. Morassi, C.P. Lombardi, G.F. Zannoni, G. Rindi, Follicular thyroid neoplasms can be classified as low- and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology. Eur. J. Endocrinol. 165, 447–453 (2011)
9. P. Trimboli, A. Crescenzi, Thyroid core needle biopsy: taking stoke of the situation. Endocrine 48, 779–785 (2015)
10. K.T. Park, S.H. Ahn, J.H. Mo, Y.J. Park, J. Park, S.I. Choi, S.Y. Park, Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head Neck 33, 160–165 (2011)
11. N. Nasrollah, P. Trimboli, L. Guidobaldi, D.D. Cicciarella Modica, C. Ventura, G. Ramacciato, S. Taccogna, F. Romanelli, S. Valabrega, A. Crescenzi, Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine 43, 659–665 (2013)
12. N. Nasrollah, P. Trimboli, F. Rossi, S. Amendola, L. Guidobaldi, C. Ventura, R. Maglio, G. Nigri, F. Romanelli, S. Valabrega, A. Crescenzi, Patient’s comfort with and tolerability of thyroid core needle biopsy. Endocrine 45, 79–83 (2014)
13. D.G. Na, J.H. Kim, J.Y. Sung, J.H. Baek, K.C. Jung, H. Lee, H. Yoo, Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the bethesda system for reporting thyroid cytopathology. Thyroid 22, 468–475 (2012)
14. Y.J. Choi, J.H. Baek, E.J. Ha, H.K. Lim, J.H. Lee, J.K. Kim, D.E. Song, Y. Shong, S.J. Hong, Different risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance (AUS) or follicular lesion of undetermined significance (FLUS): the role of US-guided core-needle biopsy (CNB). Thyroid 24, 494–501 (2014)
15. G. Fadda, F. Basolo, A. Bondi, G. Bussolati, A. Crescenzi, O. Nappi, F. Nardi, M. Papotti, G. Taddei, L. Palombini, Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica 102, 405–408 (2010)
16. R. De Lellis, R. Lloyd, P. Heitz, C. Eng, Pathology and genetics of tumour of endocrine organs, in World Health Organization classification of tumours, ed. by P. Kleihues, L. Sobin (IARC, Lyon, 2004), pp. 49–133
17. P. Trimboli, N. Nasrollah, L. Guidobaldi, S. Taccogna, D.D. Cicciarella Modica, S. Amendola, F. Romanelli, A. Lenzi, G. Nigri, M. Centanni, L. Giovanella, S. Valabrega, A. Crescenzi, The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration. World J. Surg. Oncol. 12, 61 (2014)
18. M.R. Nasr, S. Mukhopadhyay, S. Zhang, A.L. Katzenstein, Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME 1 combined with CK-19 immunostaining. Mod. Pathol. 19, 1631–1637 (2006)
19. M. Papotti, J. Rodriguez, R. De Pompa, A. Bartolazzi, J. Rosai, Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant potential. Mod. Pathol. 18, 541–546 (2005)
20. A. Bartolazzi, A. Gasbarri, M. Papotti, G. Bussolati, T. Lucante, A. Khan, H. Inohara, F. Marandino, F. Orlandi, F. Nardi, A. Vecchione, R. Tecce, O. Larsson, Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357, 1644–1650 (2001)
21. C.G. Chiu, S.S. Strugnell, O.L. Griffith, S.J. Jones, A.M. Gown, B. Walker, I.R. Nabi, S.M. Wiseman, Diagnostic utility of galectin-3 in thyroid cancer. Am. J. Pathol. 176, 2067–2081 (2010)
22. O.L. Griffith, C.G. Chiu, A.M. Gown, S.J.M. Jones, S.M. Wiseman, Biomarker panel diagnosis of thyroid cancer: a critical review. Expert Rev. Anticancer Ther. 8, 1399–1413 (2008)
23. A.A. Renshaw, N. Pinnar, Comparison of thyroid fine-needle aspiration and core needle biopsy. Am. J. Clin. Pathol. 128, 370–374 (2007)
24. D. Capper, M. Preusser, A. Habel, F. Sahm, U. Ackermann, G. Schindler, S. Pusch, G. Mechtersheimer, H. Zentgraf, A. von Deimling, Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol. 122, 11–19 (2011)
25. A. Crescenzi, L. Guidobaldi, N. Nasrollah, S. Taccogna, D.D. Cicciarella Modica, L. Turrini, G. Nigri, F. Romanelli, S. Valabrega, L. Giovanella, A. Onetti Muda, P. Trimboli, Immunohistochemistry for BRAF(V600E) antibody VE1 performed in core needle biopsy samples identifies mutated papillary thyroid cancers. Horm. Metab. Res. 46, 370–374 (2014)
26. T.J. Sebo, What are the keys to successful thyroid FNA interpretation? Clin. Endocrinol. 77, 13–17 (2012)
27. P. Trimboli, M. Bongiovanni, F. Rossi, L. Guidobaldi, A. Crescenzi, L. Ceriani, G. Nigri, S. Valabrega, F. Romanelli, L. Giovanella, Differentiated thyroid cancer patients with a previous indeterminate (Thy 3) cytology have a better prognosis than those with suspicious or malignant FNAC reports. Endocrine 49, 191–195 (2015)
28. T. Rago, M. Scutari, F. Latrofa, V. Loiacono, P. Piaggi, I. Marchetti, R. Romani, F. Basolo, P. Miccoli, M. Tonacchera, P. Vitti, The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. J. Clin. Endocrinol. Metab. 99, 3700–3707 (2014)
29. F. Nardi, F. Basolo, A. Crescenzi, G. Fadda, A. Frasoldati, F. Orlandi, L. Palombini, E. Papini, M. Zini, A. Pontecorvi, P. Vitti, Italian consensus for the classification and reporting of thyroid cytology. J. Endocrinol. Invest. 37, 593–599 (2014)
30. E.S. Cibas, S.Z. Ali, The Bethesda system for reporting thyroid cytopathology. Thyroid 19, 1159–1165 (2009)
31. A. Carpi, A.G. Naccarato, G. Iervasi, A. Nicolini, G. Bevilacqua, P. Viacava, P. Collecchi, L. Lavra, C. Marchetti, S. Sciacchitano, A. Bartolazzi, Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology. Br. J. Cancer 95, 204–209 (2006)
32. V.A. LiVolsi, S.L. Asa, The demise of follicular carcinoma of the thyroid gland. Thyroid 4, 233–236 (1994)